| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 11,300,837 | 11,545,740 | 9,554,712 | | Cost of Revenue | 8,267,612 | 8,240,930 | 6,734,635 | | | Gross Profit | 3,033,225 | 3,304,810 | 2,820,077 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,973,735 | 1,929,350 | 1,689,458 | | Non Recurring | 10,357 | 6,710 | 25,983 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,049,133 | 1,368,750 | 1,104,636 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (172,368) | (133,120) | 20,652 | | Earnings Before Interest And Taxes | 876,765 | 1,235,630 | 1,125,288 | | Interest Expense | 27,183 | 9,860 | 10,330 | | Income Before Tax | 849,582 | 1,225,770 | 1,114,958 | | Income Tax Expense | 293,327 | 480,440 | 414,924 | | Minority Interest | (68,071) | (67,900) | (52,661) | | | | Net Income From Continuing Ops | 490,449 | 678,370 | 658,839 | | | Non-recurring Events | | Discontinued Operations |
-
| 1,890 | (10,898) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 490,449 | 680,260 | 647,941 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $490,449 | $680,260 | $647,941 |
|
0.51% Nasdaq 
Income Statement
